Interleukin‐2‐inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients - Sone, Saburo; Kunishige, Eiji; Fawzy, Farid; Yanagawa, Hiroaki; Nil, Akihiko; Maeda, Ken‐ichi; Atagi, Shinji; Heike, Yuji; Nishioka, Yasuhiko; Mizuno, Kazuhito; Ogura, Takeshi (Cancer science, 1991)
Keywords: Adenocarcinoma; Aged; Biological and medical sciences; Blood; Carcinoma, Non-Small-Cell Lung; Carcinoma, Non-Small-Cell Lung - immunology; Carcinoma, Small Cell; Carcinoma, Small Cell - immunology; Cell Line; Cytokines; Cytotoxicity, Immunologic; Female; Humans; Interleukin 2; Interleukin-2 - pharmacology; Killer Cells, Lymphokine-Activated; Killer Cells, Lymphokine-Activated - immunology; Killer Cells, Natural; Killer Cells, Natural - drug effects; Killer Cells, Natural - immunology; Leukocytes (mononuclear); Lung cancer; Lung Neoplasms; Lung Neoplasms - immunology; Lymphocyte; Lymphocytes; Lymphocytes - immunology; Lymphokine-activated killer cells; Male; Medical sciences; Middle Aged; Monocyte; Monocytes; Recombinant Proteins; Recombinant Proteins - pharmacology; Reference Values; Small cell lung carcinoma; Tumors; Human; Regulation(control); Interleukin 2; Monocyte; Pathophysiology; Respiratory disease; Induction; Lung; LAK cell; Malignant tumor; Lymphocyte